Tissue Diagnostic Market Hits $ USD 6.4 Billion By 2022: Grand View Research, Inc.

1
Global Tissue Diagnostic Market Expected To
Reach USD 6.4 Billion By 2022 Grand View
Research, Inc.

• Grand View Research has announced the addition of
  "Global Tissue Diagnostic Market Analysis And
  Segment Forecasts To 2022" Market Research report
  to their Database

2

• Global tissue diagnostic market (
  http//www.grandviewresearch.com/industry-analysis
  /tissue-diagnostics-market ) is expected to reach
  USD 6.4 billion by 2022, according to a new study
  by Grand View Research Inc. Tissue diagnostic,
  due to its ability to detect cancer at an early
  stage, is expected to witness significant growth
  over the forecast period. Increasing incidences
  of breast cancer, rising geriatric population
  base and the growing demand for personalized
  medicines are high impact rendering drivers of
  the tissue diagnostics market. Furthermore,
  improving healthcare infrastructure, increasing
  demand for safe and cost effective treatment and
  rising focus of major market players on emerging
  economies such as India and China are likely to
  propel market growth. Technological advancement
  occurring in the field of tissue diagnostics is
  expected to lead towards the availability of
  better option for healthcare professionals and
  the patients. Tissue diagnostic procedures
  encompass a broad array of technologies designed
  to revolutionize the cancer diagnosis process and
  provide apt molecular information. Tissue
  diagnostic detects the presence of malignant
  cells by performing microscopic study of the
  involved tissue. This investigation is considered
  to be vital for any type of cancer in order to
  decide the most effective treatment line.

3

• Further key findings from the study suggest
• Immunohistochemistry (IHC) is identified as the
  most lucrative sub segment of the tissue
  diagnostic market majorly owing to increasing
  incidences of cancer diagnostic
• The tissue based breast cancer diagnostic
  segment accounted for the largest market share in
  2014. Rising alcohol consumption, lifestyle
  associated changes and growing geriatric
  population are some factors expected to drive
  segment growth over the forecast period.
• North America accounted for over 40.0 of the
  tissue diagnostic market in 2014 on account of
  high usage rates of technologically advanced
  products. Rising patient awareness level and the
  presence of accessible healthcare infrastructure
  is also expected to contribute towards healthy
  regional market growth.
• Asia Pacific is expected to witness the fastest
  growth over the forecast period. Rapid economic
  development and the consequent improvement of the
  healthcare infrastructure is expected to help
  manufacturers capitalize on the available
  opportunities in the form of unmet medical needs.
  Presence of sophisticated healthcare facilities
  in the developed markets of Japan and Australia
  is also expected to boost usage rates over the
  forecast period.
• Key players of the tissue diagnostic market
  include Roche Diagnostics, Cell Signaling
  Technologies, Becton Dickinson Company, Agilent
  Technologies, Abbott Laboratories, GE Healthcare,
  Thermo Fisher Scientific, Johnson Johnson and
  Danaher Corporation.
• For More http//www.grandviewresearch.com/industr
  y-analysis/tissue-diagnostics-market

4

• Request free sample of this Report
  http//www.grandviewresearch.com/industry-analysis
  /tissue-diagnostics-market/request
• For the purpose of this study, Grand View
  Research has segmented the global tissue
  diagnostic market on the basis of products,
  technology, application, end-use and region
• Global Tissue Diagnostic Product Outlook
  (Revenue, USD Million, 2012 2022)
• Instruments
• Accessories
• Global Tissue Diagnostic Technology Outlook
  (Revenue, USD Million, 2012 2022)
• Immunohistochemistry (IHC)
• In Situ Hybridization
• Special Staining
• Digital Pathology and Workflow
• Global Tissue Diagnostic Application Outlook
  (Revenue, USD Million, 2012 2022)
• Lymphoma
• Breast Cancer
• Gastric Cancer
• Prostate Cancer
• Non Small Cell Lung Cancer
• Global Tissue Diagnostic End-use Outlook
  (Revenue, USD Million, 2012 2022)

5
Tissue Diagnostic Regional Outlook (Revenue, USD
Million, 2012 2022) North America U.S. Canada Re
st of North America Europe Germany France Spain R
est of Europe Asia Pacific Japan China India Rest
of Asia Pacific Latin America Brazil Mexico Rest
of Latin America Middle East and Africa (MEA)
South Africa Rest of Middle East and Africa  
6

• Browse all reports at http//www.grandviewresearch
  .com/industry/clinical-diagnostics
• About Grand View Research
• Grand View Research, Inc. is a market research
  and consulting company that provides off-the-
  shelf, customized research reports and
  consulting services. To help clients make
  informed business decisions, we offer market
  intelligence studies, ensuring relevant and
  fact-based research across a range of industries,
  from technology to chemicals, materials and
  energy. With a deep-seated understanding of
  varied business environments, Grand View
  Research provides strategic objective insights.
•  
• Contact
• Sherry James
• Corporate Sales Specialist, USA
• Grand View Research, Inc
• Phone [phone]
• Toll Free 1-888-202-9519
• Email sales_at_grandviewresearch.com
• Website Grand View Research
• Blog Site http//www.divog.org/